Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 223, Issue 2, Pages 211-218Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2020.03.034
Keywords
acesulfame K; aspartame; non-nutritive sweeteners; pregnancy; saccharin; stevia; sucralose
Categories
Ask authors/readers for more resources
In an effort to reduce sugar consumption to prevent diabetes mellitus and cardiovascular diseases, sugar-free or no added sugar products that substitute sugar with non-nutritive sweeteners (NNSs) (eg, Splenda, Sweet'N Low, and Stevia) have become increasingly popular. The use of these products during pregnancy has also increased, with approximately 30% of pregnant women reporting intentional NNS consumption. In clinical studies with nonpregnant participants and animal models, NNSs were shown to alter gut hormonal secretion, glucose absorption, appetite, kidney function, in vitro insulin secretion, adipogenesis, and microbiome dysbiosis of gut bacteria. In pregnant animal models, NNS consumption has been associated with altered sweet taste preference later in life and metabolic dysregulations in the offspring (eg, elevated body mass index, increased risk of obesity, microbiome dysbiosis, and abnormal liver function tests). Despite the accumulating evidence, no specific guidelines for NNS consumption are available for pregnant women. Furthermore, there are limited clinical studies on the effects of NNS consumption during pregnancy and postpartum and long-term outcomes in the offspring.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available